Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 27:2024:4851392.
doi: 10.1155/2024/4851392. eCollection 2024.

Assessment of the Effects of Albendazole-Loaded Sulfonated Graphene Oxide on Echinococcus granulosus Protoscoleces: An In Vitro Investigation

Mohammad Reza Lashkarizadeh  1 , Mohammad Shafie'ei  2 , Mahdiyeh Lashkarizadeh  3 , Seyed Mohammad Mousavi  1 , Ghazaleh Sheibani  4 , Zahra Akbari  5 , Haniyeh Daneshafruz  6 , Ali Derakhshani  1 , Faham Khamesipour  7
Affiliations

Assessment of the Effects of Albendazole-Loaded Sulfonated Graphene Oxide on Echinococcus granulosus Protoscoleces: An In Vitro Investigation

Mohammad Reza Lashkarizadeh et al. J Trop Med. .

Abstract

Objectives: Due to Albendazole's relatively low efficacy and bioavailability, Echinococcosis has proven a challenge to manage successfully, with several studies investigating ways to improve the outcome, mainly showing mixed results. We, therefore, aimed to evaluate whether Sulfonated Graphene Oxide (S-GO), as nanocarriers, could improve the mentioned outcome.

Methods: Echinococcus protoscoleces were divided into four groups based on the agent they received, which comprised control, S-GO, Albendazole, and Albendazole-loaded S-GO (S-GO-Albendazole). Then, the Bax and Bcl-2 gene expression levels and the number of surviving protoscoleces in each group were determined.

Results: Bax gene expression increased by 121% in the 50 μg/ml concentration of the S-GO-Albendazole, while Bcl-2 gene expression decreased by 64%. Moreover, S-GO-Albendazole was approximately 18% more effective at neutralizing protoscoleces than Albendazole and 14% and 31% more effective at improving the expression of the mentioned genes, respectively (p < 0.05). In addition, the number of surviving protoscoleces after exposure to the mentioned concentration reduced by approximately 99%.

Conclusions: S-GO, despite not having significant lethality on protoscoleces, significantly increased the lethality of Albendazole and, therefore, is a suitable nanocarrier. However, we recommend conducting in vivo and clinical studies to more accurately determine this nanocomplex's potential and side effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Illustration of the study design.
Figure 2
Figure 2
FT-IR spectra of GO (a) and S-GO (b).
Figure 3
Figure 3
XRD patterns of S-GO.
Figure 4
Figure 4
Bax gene expression in the S-GO-ABZ, ABZ, S-GO, and control groups. However, only the increase in the S-GO-ABZ group was significant. Bars represent mean ± standard deviation (SD) from duplicate experiments. (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001) (Alb, Albendazole; Grph, S-GO).
Figure 5
Figure 5
Bcl-2 gene expression in the S-GO-ABZ, ABZ, S-GO, and control groups. However, only the decrease in the GFN-ABZ was significant. (∗∗∗p < 0.05) (Alb, Albendazole; Grph, S-GO).
Figure 6
Figure 6
(a) The dead and (b) viable protoscoleces (PSCs) after treatment with S-GO-ABZ.
Figure 7
Figure 7
Number of viable protoscoleces (PSCs) after applying different concentrations of each agent in the S-GO-ABZ, ABZ, S-GO, and control groups. However, only the decreases in the S-GO-ABZ and ABZ groups were significant (p < 0.05).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. McManus D. P., Gray D. J., Zhang W., Yang Y. Diagnosis, treatment, and management of Echinococcosis. BMJ . 2012;344(jun11 1):p. e3866. doi: 10.1136/bmj.e3866. - DOI - PubMed
    1. Budke C. M., Deplazes P., Torgerson P. R. Global socioeconomic impact of cystic Echinococcosis. Emerging Infectious Diseases . 2006;12(2):296–303. doi: 10.3201/eid1202.050499. - DOI - PMC - PubMed
    1. Brunetti E., Kern P., Vuitton D. A. Expert consensus for the diagnosis and treatment of cystic and alveolar Echinococcosis in humans. Acta Tropica . 2010;114(1):1–16. doi: 10.1016/j.actatropica.2009.11.001. - DOI - PubMed
    1. Bloom A. K., Ryan E. T. Albendazole. In: Magill A. J., Hill D. R., Solomon T., Ryan E. T., editors. Hunter’s Tropical Medicine and Emerging Infectious Disease . London, UK: W.B. Saunders; 2013. pp. 1088–1089.
    1. Cherry J., Demmler-Harrison G. J., Kaplan S. L., Steinbach W. J., Hotez P. J. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases E-Book: 2-Volume Set . Amsterdam, Netherlands: Elsevier Health Sciences; 2013.

LinkOut - more resources